ODHY yields 3.95% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, ODHY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ODHY + PFE for your $10,000?
ODHY is actively managed and invests primarily in high yield, USD-denominated corporate bonds (junk bonds). It uses a bottom-up, value-driven process in selecting securities, targeting larger companies with significant cash flow and higher-rated bonds (B3/B or better). The advisor assesses each companys credit risk through a proprietary default risk rating (DRR), which evaluates default probability, loan recovery, and other factors such as audited financial statements, restricted payments covenants, and industry classifications. Up to 10% may be allocated to government securities, higher-rated bonds, or unrated/lower-rated bonds if DRR equivalents meet established criteria. The fund may engage in frequent trading during periods of volatility to optimize returns or limit losses. Industry exposure is capped at 15%, issuer holdings at 1.5%, and the weighted average rating is maintained at B2/B.
Full ODHY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.